Poltreg Spolka Akcyjna

Where the EU money came from

Funding by EU programme. Amounts are Poltreg Spolka Akcyjna's own share of each project, not the project's full budget.

Projects

3 EU-funded projects, newest first. Poltreg Spolka Akcyjna led 2 of them as coordinator. Each links to the official record.

• ARTiDePartner

  Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €806ktheir share
• TREGCoordinator

  TREG – innovative cell therapy targeting Diabetes Type 1

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  €2.5Mtheir share
• TREGS4DM1Coordinator

  Commercialization of TREG cells sorting and proliferation in vitro for the production of vaccines for the treatment of type 1 diabetes.

  Horizon 2020 · 2016–2016 · Project on CORDIS ↗

  €50ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Technische Universitat BerlinGermany · 1 shared project
• Assistance Publique Hopitaux de ParisFrance · 1 shared project
• Institut CurieFrance · 1 shared project
• Christian-Albrechts-Universitaet zu KielGermany · 1 shared project
• Universite Paris CiteFrance · 1 shared project
• Universitatsklinikum Schleswig-HolsteinGermany · 1 shared project
• Inserm Transfert SAFrance · 1 shared project
• Miltenyi Biotec BV & Co KGGermany · 1 shared project
• Iltoo PharmaFrance · 1 shared project
• Breakthrough T1dUnited States · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• autoimmune diseases
• cells technologies
• diabetes
• immunology
• kidney diseases
• mortality
• vaccines